Hasegawa R, Miyata E, Futakuchi M, Hagiwara A, Nagao M, Sugimura T, Ito N
First Department of Pathology, Nagoya City University Medical School, Japan.
Carcinogenesis. 1994 May;15(5):1037-41. doi: 10.1093/carcin/15.5.1037.
Potential synergism between 10 carcinogenic heterocyclic amines [3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), 2-amino-6 methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1), 2-amino-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoline (MeIQ), 2-amino-3,8-dimethyl-imidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C), 2-amino-9H-pyrido[2,3-b]indole (A alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)] in rat liver carcinogenesis was examined. Male F344 rats were initially given diethylnitrosamine (200 mg/kg, i.p.) and beginning 2 weeks later received heterocyclic amines individually at doses 1/10 of that proven to be carcinogenic or in combination at 1/10 or 1/100 doses for 6 weeks. All animals were subjected to partial hepatectomy at week 3 and killed at week 8. The induction of immunohistochemically demonstrable placental glutathione S-transferase positive foci was significantly increased in rats given all 10 chemicals in combination at the 1/10 dose level while values were almost the same as in controls with the 1/100 dose mixture and the individual chemicals, except for Glu-P-1 which significantly increased foci development and Glu-P-2 and A alpha c which significantly decreased levels of foci at the 1/10 dose level. Thus apparent synergism was observed with the 1/10 dose level combination. When the data are considered together with our previous results obtained with five heterocyclic amines using 1/1, 1/5 and 1/25 dose levels, combined effects were found to be related to the number of chemicals included and the dose levels of each, with a possible isoadditive influence being common. The findings are of particular significance since heterocyclic amines and other carcinogenic agents might be simultaneously generated during cooking.
研究了10种致癌杂环胺[3-氨基-1,4-二甲基-5H-吡啶并[4,3-b]吲哚(Trp-P-1)、3-氨基-1-甲基-5H-吡啶并[4,3-b]吲哚(Trp-P-2)、2-氨基-6-甲基二吡啶并[1,2-a:3',2'-d]咪唑(Glu-P-1)、2-氨基二吡啶并[1,2-a:3',2'-d]咪唑(Glu-P-2)、2-氨基-3-甲基咪唑并[4,5-f]喹啉(IQ)、2-氨基-3,4-二甲基咪唑并[4,5-f]喹啉(MeIQ)、2-氨基-3,8-二甲基咪唑并[4,5-f]喹喔啉(MeIQx)、2-氨基-3-甲基-9H-吡啶并[2,3-b]吲哚(MeAαC)、2-氨基-9H-吡啶并[2,3-b]吲哚(AαC)和2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)]在大鼠肝癌发生过程中的潜在协同作用。雄性F344大鼠最初腹腔注射二乙基亚硝胺(200mg/kg),2周后开始分别给予剂量为已证实致癌剂量1/10的杂环胺,或按1/10或1/100剂量联合给予,持续6周。所有动物在第3周接受部分肝切除术,并在第8周处死。在1/10剂量水平联合给予所有10种化学物质的大鼠中,免疫组化可检测到的胎盘谷胱甘肽S-转移酶阳性灶的诱导显著增加,而在1/100剂量混合物和单独使用化学物质的情况下,其值与对照组几乎相同,但Glu-P-1在1/10剂量水平时显著增加灶的形成,Glu-P-2和AαC在1/10剂量水平时显著降低灶的水平。因此,在1/10剂量水平联合使用时观察到明显的协同作用。当将这些数据与我们之前使用1/1、1/5和1/25剂量水平的五种杂环胺获得的结果综合考虑时,发现联合效应与所含化学物质的数量及其各自的剂量水平有关,可能存在共同的等加性影响。这些发现具有特别重要的意义,因为杂环胺和其他致癌剂可能在烹饪过程中同时产生。